Suppr超能文献

一名免疫功能低下患者接种带状疱疹疫苗后发生致命性播散性水痘-带状疱疹病毒感染。

Fatal disseminated varicella zoster infection following zoster vaccination in an immunocompromised patient.

作者信息

Costa E, Buxton J, Brown J, Templeton K E, Breuer J, Johannessen I

机构信息

Royal Infirmary of Edinburgh, Edinburgh, UK.

Borders General Hospital, Melrose, UK.

出版信息

BMJ Case Rep. 2016 May 4;2016:bcr2015212688. doi: 10.1136/bcr-2015-212688.

Abstract

A 79-year-old man with chronic lymphocytic leukaemia presented with fever and a widespread vesicular rash on 19 November 2014. The patient had not been under immunosuppressive regime for 6 months. He had received a shingles vaccine on 14th October and developed flu-like symptoms after 2 weeks. Intravenous antimicrobial therapy including aciclovir was started. He remained stable with no evidence of systemic involvement. On day 5, he developed respiratory and renal failure that required transfer to intensive care unit. Vesicle fluid, bronchoalveolar lavage and plasma were positive for varicella zoster virus by PCR. Slight clinical improvement allowed extubation on day 16. He subsequently deteriorated and died on day 25. Multiorgan failure was considered the immediate cause of death whereas disseminated varicella zoster infection was stated in the medical certificate as the other condition leading to this outcome. Varicella zoster Oka vaccine strain was detected in vesicle fluid, using PCR.

摘要

一名79岁的慢性淋巴细胞白血病男性患者于2014年11月19日出现发热及广泛的水疱疹。患者已6个月未接受免疫抑制治疗。他于10月14日接种了带状疱疹疫苗,2周后出现流感样症状。开始了包括阿昔洛韦在内的静脉抗菌治疗。他病情保持稳定,无全身受累迹象。第5天,他出现呼吸和肾衰竭,需要转入重症监护病房。通过聚合酶链反应(PCR)检测,水疱液、支气管肺泡灌洗物和血浆中水痘带状疱疹病毒呈阳性。第16天,轻微的临床改善使患者得以拔管。随后他病情恶化,于第25天死亡。多器官功能衰竭被认为是直接死因,而医疗证明中指出播散性水痘带状疱疹感染是导致这一结果的另一情况。使用PCR在水疱液中检测到水痘带状疱疹Oka疫苗株。

相似文献

1
Fatal disseminated varicella zoster infection following zoster vaccination in an immunocompromised patient.
BMJ Case Rep. 2016 May 4;2016:bcr2015212688. doi: 10.1136/bcr-2015-212688.
2
Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection.
Vaccine. 2018 Jun 22;36(27):3890-3893. doi: 10.1016/j.vaccine.2018.05.078. Epub 2018 May 25.
3
Chronic herpes zoster duplex bilateralis.
Acta Derm Venereol. 2012 Mar;92(2):148-51. doi: 10.2340/00015555-1206.
4
Disseminated vaccine-induced varicella infection in a kidney transplant recipient.
Am J Transplant. 2023 Nov;23(11):1806-1810. doi: 10.1016/j.ajt.2023.05.034. Epub 2023 Jun 5.
5
Zoster vaccine-associated primary varicella infection in an immunocompetent host.
BMJ Case Rep. 2017 Aug 22;2017:bcr-2017-221166. doi: 10.1136/bcr-2017-221166.
6
Acute Retinal Necrosis Caused by the Zoster Vaccine Virus.
Clin Infect Dis. 2017 Nov 29;65(12):2122-2125. doi: 10.1093/cid/cix683.
7
Herpes zoster due to Oka vaccine strain of varicella zoster virus in an immunosuppressed child post cord blood transplant.
J Paediatr Child Health. 2007 Oct;43(10):713-5. doi: 10.1111/j.1440-1754.2007.01191.x.
8
Pediatric vaccine-strain herpes zoster: a case series.
Pediatr Dermatol. 2017 Nov;34(6):665-667. doi: 10.1111/pde.13265. Epub 2017 Sep 25.
9
Vaccines for preventing herpes zoster in older adults.
Cochrane Database Syst Rev. 2023 Oct 2;10(10):CD008858. doi: 10.1002/14651858.CD008858.pub5.

引用本文的文献

2
Insights into pathologic mechanisms occurring during serious adverse events following live zoster vaccination.
J Virol. 2025 Feb 25;99(2):e0181624. doi: 10.1128/jvi.01816-24. Epub 2025 Jan 17.
3
Vaccination of Adults With Cancer: ASCO Guideline.
J Clin Oncol. 2024 May 10;42(14):1699-1721. doi: 10.1200/JCO.24.00032. Epub 2024 Mar 18.
4
Vaccinations in patients with chronic lymphocytic leukemia.
Semin Hematol. 2024 Apr;61(2):131-138. doi: 10.1053/j.seminhematol.2024.01.003. Epub 2024 Jan 6.
5
Vaccine schedule recommendations and updates for patients with hematologic malignancy post-hematopoietic cell transplant or CAR T-cell therapy.
Transpl Infect Dis. 2023 Nov;25 Suppl 1(Suppl 1):e14109. doi: 10.1111/tid.14109. Epub 2023 Jul 29.
6
Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients.
Viruses. 2023 Feb 5;15(2):439. doi: 10.3390/v15020439.
10
BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL.
Blood Adv. 2022 Mar 22;6(6):1732-1740. doi: 10.1182/bloodadvances.2021006574.

本文引用的文献

1
The herpes zoster subunit vaccine.
Expert Opin Biol Ther. 2016;16(2):265-71. doi: 10.1517/14712598.2016.1134481.
2
Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
N Engl J Med. 2015 May 28;372(22):2087-96. doi: 10.1056/NEJMoa1501184. Epub 2015 Apr 28.
4
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients.
Blood. 2014 Nov 6;124(19):2921-9. doi: 10.1182/blood-2014-04-573048. Epub 2014 Sep 18.
5
Varicella and herpes zoster vaccines: WHO position paper, June 2014.
Wkly Epidemiol Rec. 2014 Jun 20;89(25):265-87.
6
Clinical and molecular aspects of the live attenuated Oka varicella vaccine.
Rev Med Virol. 2014 Jul;24(4):254-73. doi: 10.1002/rmv.1789. Epub 2014 Mar 29.
7
Fatal varicella due to the vaccine-strain varicella-zoster virus.
Hum Vaccin Immunother. 2014;10(1):146-9. doi: 10.4161/hv.26200. Epub 2013 Aug 27.
8
Varicella vaccination in a child with acute lymphoblastic leukaemia.
Lancet. 2007 Apr 7;369(9568):1232. doi: 10.1016/S0140-6736(07)60567-4.
9
Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus.
J Virol. 2002 Nov;76(22):11447-59. doi: 10.1128/jvi.76.22.11447-11459.2002.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验